Regarding cancer treatment, two key effects of TNF blockers on the immune system in patients with inflammatory diseases are noteworthy: they modulate TReg cell activity and reduce T-helper cell inflammatory responses by decreasing IL-17 production (55). This evidence concerns the gene TNF and cancer.